Advertisement

Topics

Companies Related to "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum" [Most Relevant Company Matches] - Page: 20 RSS

07:57 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum" found in our extensive corporate database of over 50,000 company records.

Showing "Phase Study AZD6244 Combination With Capecitabine Radiotheraphy Locally" Companies 476–500 of 1,600+

Probably Relevant

CarrollDrugs.Com - The online department of Taneytown Pharmacy

Carroll Drugs offers full line pharmacy services and features hormone replacement therapy with local and national delivery. In addition to traditional prescriptions, we compound medications specific to each patient by order of a physician, such as hormone replacement therapy. E-mail or call us us to find out about our VERY reasonable prices on drugs and compounds like bio-identical hormone replac...


GTS Medical Translation Services

GTS provides certified medical translation services to leading pharmaceutical companies, medical device companies and CROs. Customers include Astra Zeneca, GSK, Teva Pharmaceuticals, Siemens, Boston Scientific, INC Research, Shire and others. We support over 60 languages; this includes all the major European, Asian, Scandinavian and Middle-Eastern languages. We translate the following types of...

BioSante Pharmaceuticals, Inc.

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol...


Heat Biologics, Inc.

Heat Biologics (www.heatbio.com) (“Heat”) is a clinical-stage company immunotherapy company focused on developing its novel off-the-shelf “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) therapeutic vaccines to combat a wide range of cancers and other diseases. Heat’s ImPACT Therapy effectively reprograms tumor cells to “pump o...

Harrison Clinical Research

Since 1987, we have established affiliate offices in the UK (1992), Benelux (1996), Israel (1998), Spain and France (2000), Italy (2002), Austria, serving Eastern Europe (2004) as well as in Russia, Ukraine and Poland (2007) and we have representative offices in Japan and USA. All our affiliate offices offer complate monitoring of clinical studies from Phase II-IV and local consultancy. Over the...

Omnicare Clinical Research

Omnicare Clinical Research is one of the world’s leading CROs. With 32 offices worldwide and a presence in 44 countries, we provide a comprehensive scope of services in Phase I-IV clinical trials for all major therapeutic areas. Since 1985, the Biopharmaceutical industry has entrusted our team to handle their drug development needs. For late phase projects, we also feature a Peri-Approval & Geri...

PH&T S.p.A

PH&T S.p.A. is a privately owned Italian pharmaceutical company, founded in 1991 by senior managers with established experience in the pharmaceutical industry.The mission of PH&T is to develop ethical pharmaceuticals for niche therapeutical areas. PH&T portfolio includes not only generics but also new formulations of established out-of-patent drugs. PH&T is specialised in products which require hi...

ArQule, Inc.

ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company’s targeted, broad-spectrum products and research programs are focused on key biological processes that are central to human cancers. ArQule’s lead product, in Phase 2 clinical development, is ARQ 197, an in...

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. is engaged in the discovery and commercialization of new therapeutics that treat serious and life-threatening diseases, with a particular focus on the growing worldwide problem of antibiotic resistance. Paratek is advancing novel compounds that can circumvent or block bacterial resistance involving technology initially developed by Paratek co-founder Dr. Stuart Levy's...

BIOforward, Inc.

BIOforward is a member-driven association and nonprofit corporation with the vision to improve lives around the world by supporting life science innovation in Wisconsin. Our mission is to advance Wisconsin’s position as a leading life science economy, by providing members with: advocacy locally and nationally; education to strengthen our industry; con...

Algemene Communicatie en Netwerk Integratie

A.C.N.I. provides solutions for Internet Integration projects. From study, advise to integration, sourcing and coordination. A.C.N.I. helps your company to get results form using the high speed Internet.

BBK Health care

the industry leader in providing clinical trial sponsors the best in global study enrollment services. To learn more about our company, staff, and contributions to the clinical R&D industry, please visit the sections below.

Invicro LLC

Based in Boston, MA, Invicro was founded in 2008 with the mission of improving the role and function of imaging in translational drug discovery and development across all therapeutic areas. Invicro’s multi-disciplinary team provides a full range of image informatics, engineering and operational services. Originally focused on imaging in discovery phas...

BioSphere Medical

Since 1999, BioSphere Medical's primary mission has been to be a global leader in embolotherapy. The Company is pioneering the use of patented bioengineered microspheres as a new class of embolics for the treatment of tumors and vascular malformations by occluding their blood supply. We are driving demand for our proprietary microsphere technology as we penetrate additional key markets and launch ...

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and cancer. X4’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. X4’s most advanced product candidate, X4P-001, is in a Ph...

Atopix Therapeutics Ltd

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel class of oral anti-allergic medicines, called CRTH2 antagonists, to treat atopic dermatitis, asthma and allergic rhinitis. Its lead candidate is currently being studied in a Phase 2 clinical trial for severe atop...

Hylant Group

Founded in 1935, Hylant Group is a full-service insurance brokerage with 12 offices in Ohio, Michigan, Illinois, Indiana and Tennessee, and employs more than 625 employees. As a member of the Worldwide Broker Network, Hylant offers complete risk management services, employee benefits consultation, loss control, 401(k) and financial services, healthcare management and insurance solutions for busine...

RTL

° Phase I through Phase IV clinical trials for the development of prescription and OTC drugs, and dental and oral health products. ° New product development to test the relative safety and efficacy of experimental products or product ingredients. ° Testing to substantiate advertising claims.° Our Clinical Research Organization consists of a team of professionals trained in all phases of clinic...

Clearblue

Clearblue is the world’s leading brand in home pregnancy and fertility testing. The Clearblue product range is built on a strong foundation of peer-reviewed science and consumer understanding. Clearblue products are also trusted and recommended by doctors, many of whom recognize that Clearblue is supported by 25 years of expertise, quality, and innovation ...

Xhale Innovations, Inc.

Xhale Innovations, Inc., a subsidiary of Xhale, Inc., is making strides in safeguarding health through technology. Xhale was formed in 2005 following six years of research and intellectual property development at the University of Florida, Gainesville. Xhale is funded by private equity investment, and has been awarded two NIH SBIR Phase I grants and one NI...

ZymeQuest, Inc

ZymeQuest is developing and will manufacture and sell enzymatic conversion systems to regional blood centers for use in converting groups A, B and AB red blood cells to enzyme converted group O (ECO) red blood cells.Our enzyme conversion system consists of:Enzymes to convert non-O red cells to ECO red cells.Specific solutions and reagents needed to perform enzyme conversion.A fully automated devic...

Otonomy Inc.

Otonomy is an emerging biopharmaceutical company based in San Diego that is focused on the development and commercialization of novel treatments for diseases of the inner and middle ear. This field represents a large untapped opportunity with nearly 30 million Americans facing debilitating hearing and balance disorders. Currently, no approved drug treatments exist for these conditions. In addition...

Lucile Packard Children’s Hospital

Ranked as one of the nation's best pediatric hospitals by U.S.News & World Report, Lucile Packard Children's Hospital at Stanford is a 312-bed hospital devoted to the care of children and expectant mothers. Providing pediatric and obstetric medical and surgical services and associated with the Stanford University School of Medicine, Packard Children's offe...

QSV Biologics Ltd.

QSV Biologics provides dedicated biopharmaceutical contract manufacturing services for process development & scale-up, pre-clinical research, Phase I, II and III clinical trials materials to biopharmaceutical firms developing protein therapeutic products. QSV was established in 2002 although the GMP manufacturing facility has been in operation since 1996. In early 2005 QSV completed commissioning...

Rexahn Pharmaceuticals

Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer, central nervous system disorders and other unmet medical needs. Our motto is "Saving Lives Through Innovation," which represents the Company's use of scientific innovation to improve the health and wellness of patients. We develop ...


More From BioPortfolio on "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks